Avdoralimab Biosimilar(Anti-Complement C5aR1 Reference Antibody) Datasheet DC Chemicals
Description
Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research.